Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Natalie Moshayedi"'
Autor:
Jun Gong, Shant Thomassian, Sungjin Kim, Gillian Gresham, Natalie Moshayedi, Jason Y. Ye, Julianne C. Yang, Jonathan P. Jacobs, Simon Lo, Nick Nissen, Srinivas Gaddam, Mourad Tighiouart, Arsen Osipov, Andrew Hendifar
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract In this phase I dose-escalation trial, we assess the maximum tolerated dose (MTD) of Bermekimab in combination with Nanoliposomal Irinotecan (Nal-Iri) and 5-Fluorouracil/Folinic Acid (5-FU/FA). Secondarily, we investigate effects on weight,
Externí odkaz:
https://doaj.org/article/e263745a6ab941d78e370e228fec8e54
Autor:
Jun Gong, Shant Thomassian, Sungjin Kim, Gillian Gresham, Natalie Moshayedi, Jason Y. Ye, Julianne C. Yang, Jonathan P. Jacobs, Simon Lo, Nick Nissen, Srinivas Gaddam, Mourad Tighiouart, Arsen Osipov, Andrew Hendifar
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/640e6329850e4dc780890c2142ce19ef
Autor:
Camille F, Ng, John, Glaspy, Veronica R, Placencio-Hickok, Shant, Thomassian, Jun, Gong, Arsen, Osipov, Andrew E, Hendifar, Natalie, Moshayedi
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:1076-1079
Despite advances in cancer therapeutics, pancreatic ductal adenocarcinoma (PDAC) remains among the deadliest malignancies, with a poor prognosis at time of diagnosis. Research in PDAC has suggested that adaptive signaling in the tumor microenvironmen
Autor:
Gong, Hayato Muranaka, Andrew Hendifar, Arsen Osipov, Natalie Moshayedi, Veronica Placencio-Hickok, Nicholas Tatonetti, Aleksandr Stotland, Sarah Parker, Jennifer Van Eyk, Stephen J. Pandol, Neil A. Bhowmick, Jun
Publikováno v:
Cancers; Volume 15; Issue 11; Pages: 3020
Pancreatic cancer (PC) is one of the deadliest cancers. Developing biomarkers for chemotherapeutic response prediction is crucial for improving the dismal prognosis of advanced-PC patients (pts). To evaluate the potential of plasma metabolites as pre
Autor:
Patrick C Lee, Edik M Blais, Jun Gong, Arsen Osipov, Natalie Moshayedi, Shant Thomassian, Camille Ng, Jennifer Chuy, Lynn M Matrisian, III Emanuel F Petricoin, Michael J Pishvaian, Andrew E Hendifar
Publikováno v:
Endocrine Abstracts.
Autor:
Andrew Hendifar, Rasaq Akinsola, Hayato Muranaka, Arsen Osipov, Shant Thomassian, Natalie Moshayedi, Julianne Yang, Jonathan Jacobs, Suzanne Devkota, Neil Bhowmick, Jun Gong
Publikováno v:
World journal of gastrointestinal oncology, vol 14, iss 7
Nearly 80% of patients with pancreatic ductal adenocarcinoma (PDAC) develop cachexia along their disease course. Cachexia is characterized by progressive weight loss, muscle wasting, and systemic inflammation and has been linked to poorer outcomes an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9b27c5144ba8eebbe357ae3b45385ca
https://escholarship.org/uc/item/9m71w5bk
https://escholarship.org/uc/item/9m71w5bk
Autor:
John Davelaar, Anser A. Abbas, Angela Minasyan, Omer H. Elmadbouh, Natalie Moshayedi, Brent Larson, Nicholas Nissen, Simon Lo, Srinivas Gaddam, Kambiz Kosari, Jun Gong, Andrew Hendifar, Stephen Pandol, Arsen Osipov
Publikováno v:
Cancer Research. 83:5854-5854
Background: PDAC is an aggressive and treatment-refractory cancer due to its desmoplastic and immunosuppressive tumor microenvironment (TME). Overexpression of pFAK, a master regulator of the TME, and CXCR4, a receptor involved immunosuppression and
Autor:
Stephen J. Pandol, Arsen Osipov, Andrew Eugene Hendifar, Sungjin Kim, Marie Lauzon, Jun Gong, Michelle Guan, Nicholas N. Nissen, Veronica Placencio-Hickok, Brent K. Larson, Simon S. Lo, Natalie Moshayedi
Publikováno v:
Pancreatology
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], vol 22, iss 1
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], vol 22, iss 1
BackgroundPancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive cancers with poor survival. The dense desmoplastic stroma in PDAC contributes to treatment resistance. Among the components comprising the tumor stroma, hyaluronan (HA) h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa6225d4dc0563e1a9a92e444c18f5e5
https://europepmc.org/articles/PMC8903049/
https://europepmc.org/articles/PMC8903049/
Autor:
Lyanne Oblein, Michael Horowitz, Mahmudul Hasan, Sruthi Babu, Mariana Torrente-Goncalves, Lucia Roa, Jaymie Oentoro, Jason Harper, Xin Yao Zheng, Wei Jiang, Andrew Hendifar, Natalie Moshayedi, Brent Larson, Veronica Placencio-Hickok, Edik Blais, Emmanuel Petricoin, Joel Saltz, Natalia D. Marchenko, Luisa F. Escobar-Hoyos, Kenneth Shroyer
Publikováno v:
Cancer Research. 82:C071-C071
Background: Keratin 17 (K17) is a negative prognostic biomarker, overexpressed in the biologically most aggressive forms of pancreatic ductal adenocarcinoma (PDAC). In other anatomic sites and disease processes, K17 expression also correlates with im
Autor:
Rasaq Akinsola, Hayato Muranaka, Andrew Eugene Hendifar, Arsen Osipov, Natalie Moshayedi, Shant Thomassian, Aleksandr Stotland, Sarah Parker, Jennifer Van Eyk, Suzanne Devkota, Neil Bhowmick, Jun Gong
Publikováno v:
Journal of Clinical Oncology. 40:e16291-e16291
e16291 Background: We previously showed that enteral feeding was associated with weight stability and compositional changes in the gut microbiome with increased abundance of the gram-negative genera Veillonella over time. Here, we evaluated the poten